DNA damage and repair in type 2 diabetes mellitus.

DNA damage may be associated with type 2 diabetes mellitus (T2DM) and its complications mainly through oxidative stress. Little is known about DNA repair disturbances potentially contributing to the overall extent of DNA damage in T2DM, which, in turn, may be linked with genomic instability resulting in cancer. To assess whether DNA repair may be perturbed in 2DM we determined: (1) the level of endogenous basal DNA damage, this means damage recognized in the alkaline comet assay (DNA strand breaks and alkali labile sites) as well as endogenous oxidative and alkylative DNA damage (2) the sensitivity to DNA-damaging agents hydrogen peroxide and doxorubicin and the efficacy of removing of DNA damage induced by these agents in peripheral blood lymphocytes of T2DM patients and healthy individuals. The level of DNA damage and the kinetics of DNA repair was evaluated by the alkaline single cell gel electrophoresis (comet assay). Oxidative and alkylative DNA damage were assayed with the use of DNA repair enzymes endonuclease III (Endo III) and formamidopyrimidine-DNA glycosylase (Fpg), recognizing oxidized DNA bases and 3-methyladenine-DNA glycosylase II (AlkA) recognizing alkylated bases. The levels of basal endogenous and oxidative DNA damage in diabetes patients were higher than in control subjects. There was no difference between the level of alkylative DNA in the patients and the controls. Diabetes patients displayed higher susceptibility to hydrogen peroxide and doxorubicin and decreased efficacy of repairing DNA damage induced by these agents than healthy controls. Our results suggest that type 2 diabetes mellitus may be associated not only with the elevated level of oxidative DNA damage but also with the increased susceptibility to mutagens and the decreased efficacy of DNA repair. These features may contribute to a link between diabetes and cancer and metrics of DNA damage and repair, measured by the comet assay, may be markers of risk of cancer in diabetes.

[1]  I. Stewart,et al.  Histopathology and Mismatch Repair Status of 458 Consecutive Colorectal Carcinomas , 2003, The American journal of surgical pathology.

[2]  B. Halliwell,et al.  Increased oxidative damage to all DNA bases in patients with type II diabetes mellitus , 1999, FEBS letters.

[3]  J. Quiles,et al.  Antioxidant nutrients and adriamycin toxicity. , 2002, Toxicology.

[4]  W. Jarnagin,et al.  Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer , 2002, Journal of Gastrointestinal Surgery.

[5]  M. O'Kane,et al.  Levels of peripheral blood cell DNA damage in insulin dependent diabetes mellitus human subjects. , 2000, Mutation research.

[6]  A. Collins,et al.  DNA damage in diabetes: correlation with a clinical marker. , 1998, Free radical biology & medicine.

[7]  J. Drai,et al.  Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[8]  H. K. Lee,et al.  Serum 8-hydroxy-guanine levels are increased in diabetic patients. , 2001, Diabetes care.

[9]  P. Newcomb,et al.  Diabetes, body size, and risk of endometrial cancer. , 1998, American journal of epidemiology.

[10]  K. Panda,et al.  Vitamin C prevents cigarette smoke-induced oxidative damage in vivo. , 2000, Free radical biology & medicine.

[11]  S. Toledo,et al.  Increased single strand breaks in DNA of lymphocytes from diabetic subjects. , 1987, The Journal of clinical investigation.

[12]  D. Talwar,et al.  Dietary flavonols protect diabetic human lymphocytes against oxidative damage to DNA. , 1999, Diabetes.

[13]  D. Livingston,et al.  In search of the tumour-suppressor functions of BRCA1 and BRCA2 , 2000, Nature.

[14]  J Ashby,et al.  The single cell gel electrophoresis assay for induced DNA damage (comet assay): measurement of tail length and moment. , 1995, Mutagenesis.

[15]  A. Paradiso,et al.  Breast cancer: biological characteristics in postmenopausal type 2 diabetic women. Identification of therapeutic targets. , 2003, Current drug targets. Immune, endocrine and metabolic disorders.

[16]  D L McGee,et al.  Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study , 1979, Diabetes Care.

[17]  M. Chung,et al.  8-oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Giovannucci.  Insulin, insulin-like growth factors and colon cancer: a review of the evidence. , 2001, The Journal of nutrition.

[19]  E. Calle,et al.  Colorectal cancer: another complication of diabetes mellitus? , 1998, American journal of epidemiology.

[20]  E. Gajewski,et al.  Substrate specificity of the Escherichia coli Fpg protein (formamidopyrimidine-DNA glycosylase): excision of purine lesions in DNA produced by ionizing radiation or photosensitization. , 1992, Biochemistry.

[21]  C. Ioannides,et al.  An examination of DNA strand breakage in the comet assay and antioxidant capacity in diabetic patients. , 1998, Mutation research.

[22]  J. Vertommen,et al.  Oxidative stress status in patients with diabetes mellitus: relationship to diet , 2003, European Journal of Clinical Nutrition.

[23]  O. Aruoma,et al.  Oxidative damage in pregnant diabetic rats and their embryos. , 2000, Free radical biology & medicine.

[24]  M. Evans,et al.  DNA repair and its pathogenetic implications. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[25]  P O'Neill,et al.  Clustered DNA Damage, Influence on Damage Excision by XRS5 Nuclear Extracts and Escherichia coli Nth and Fpg Proteins* , 2000, The Journal of Biological Chemistry.

[26]  R. Tice,et al.  Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing , 2000, Environmental and molecular mutagenesis.

[27]  J. Nygren,et al.  The comet assay: mechanisms and technical considerations. , 1996, Mutation research.

[28]  L. Giovannelli,et al.  Oxidative DNA damage in peripheral blood cells in type 2 diabetes mellitus: higher vulnerability of polymorphonuclear leukocytes. , 2003, Mutation research.

[29]  A. Collins,et al.  Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA. , 1993, Carcinogenesis.

[30]  S. Mocellin,et al.  Pharmacokinetics of intraperitoneal cisplatin and doxorubicin. , 2003, Surgical oncology clinics of North America.

[31]  J. Laval.  Two enzymes are required for strand incision in repair of alkylated DNA , 1977, Nature.

[32]  A. V. van Zeeland,et al.  Activity of Escherichia coli DNA-glycosylases on DNA damaged by methylating and ethylating agents and influence of 3-substituted adenine derivatives. , 1998, Mutation research.

[33]  R. Perfetti,et al.  Insulin and glucose regulate the expression of the DNA repair enzyme XPD , 2003, Molecular and Cellular Endocrinology.

[34]  J. Meyerhardt,et al.  Impact of diabetes mellitus on outcomes in patients with colon cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  G. King,et al.  Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications. , 2003, Journal of the American Society of Nephrology : JASN.

[36]  H Terato,et al.  Oxidative DNA damage induced by high glucose and its suppression in human umbilical vein endothelial cells. , 2001, Mutation research.

[37]  T. Skorski,et al.  Free radical scavengers can differentially modulate the genotoxicity of amsacrine in normal and cancer cells. , 2003, Mutation research.

[38]  N. Rifai,et al.  Association of markers of insulin and glucose control with subsequent colorectal cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[39]  H. İlkova,et al.  Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. , 2002, Mutation research.

[40]  T. Nicotera,et al.  Oxidative damage to DNA in diabetes mellitus , 1996, The Lancet.

[41]  B. Halliwell,et al.  Loss of oxidized and chlorinated bases in DNA treated with reactive oxygen species: implications for assessment of oxidative damage in vivo. , 2002, Biochemical and biophysical research communications.

[42]  V. Kouloulias,et al.  Prognostic Factors for Survival in Invasive Squamous Cell Vulvar Carcinoma: A Univariate Analysis , 2001, Gynecologic and Obstetric Investigation.

[43]  M. Yokoyama,et al.  Anthropometric and Other Risk Factors for Ovarian Cancer in a Case‐Control Study , 1998, Japanese journal of cancer research : Gann.

[44]  R. L. Presti,et al.  Diabetes mellitus: oxidative stress and wine , 2003, Current medical research and opinion.

[45]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.